Metsera, Inc.
Why Robinhood?
You can watch Metsera, Inc. and buy or sell other stocks, ETFs, and their options commission-free!About MTSR
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
MTSR Key Statistics
Stock Snapshot
As of today, Metsera, Inc.(MTSR) shares are valued at $70.50. The company's market cap stands at 7.41B, with a P/E ratio of -23.55.
Metsera, Inc.(MTSR) stock opened on 2026-05-08 at —. The price climbed to — and dipped to —.
Metsera, Inc.(MTSR) shares are trading with a volume of 0, against a daily average of 4.34M.
In the last year, Metsera, Inc.(MTSR) shares hit a 52-week high of $83.86 and a 52-week low of $12.30.
In the last year, Metsera, Inc.(MTSR) shares hit a 52-week high of $83.86 and a 52-week low of $12.30.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.